The Journal of Immunology, Vol 155, Issue 2 958-966, Copyright © 1995 by American Association of Immunologists

ARTICLES

Immunization of a rabbit with beta 2-glycoprotein I induces charge- dependent crossreactive antibodies that bind anionic phospholipids and have similar reactivity as autoimmune anti-phospholipid antibodies

S Kouts, MX Wang, S Adelstein and SA Krilis
Department of Immunology, Allergy and Infectious Disease, University of New South Wales, St. George Hospital, Kogarah, Australia.

A rabbit immunized with beta 2-glycoprotein I (beta 2-GPI) produced Abs that bind to negatively charged phospholipids and to beta 2-GPI. After affinity purification of the Abs to beta 2-GPI, the dual reactivity could still be detected. Adsorption studies with a phosphatidylserine affinity column depleted phospholipid-reactive Abs, but beta 2-GPI reactivity was retained. The same pattern of reactivity was found with culture supernatants from rabbit anti-beta 2-GPI splenocytes fused with an immortalized rabbit cell line. The reactivity to negatively charged phospholipids is likely to involve ionic interactions, as high ionic strength buffers eliminated binding to anionic phospholipids, but not to beta 2-GPI. Affinity-purified anti-phospholipid (aPL) Abs from four of seven autoimmune patients bound anionic phospholipids in the absence of beta 2-GPI. However, in high ionic strength buffer, this binding was abolished in three patients and significantly reduced in the fourth. In contrast, affinity-purified aPL Abs from seven autoimmune patients bound to beta 2-GPI-coated plates, and binding in high ionic strength buffer was reduced only moderately in three patients. Therefore, autoimmune-type aPL Abs display anti-beta 2-GPI reactivity and charge- dependent binding to anionic phospholipids similar to affinity-purified rabbit anti-beta 2-GPI Abs.

This article has been cited by other articles:

				S. von Gunten, A. Schaub, M. Vogel, B. M. Stadler, S. Miescher, and H.-U. Simon Immunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparations Blood, December 15, 2006; 108(13): 4255 - 4259. [Abstract] [Full Text] [PDF]

				S W Reddel, Y X Wang, and S A Krilis Anti-{beta}2-glycoprotein I autoantibodies require an antigen density threshold, consistent with divalent binding Lupus, January 1, 2003; 12(1): 37 - 45. [Abstract] [PDF]

				I Takeda, K Rayno, F B Movafagh, M Wolfson-Reichlin, and M Reichlin Dual binding capabilities of anti-double-stranded DNA antibodies and anti-ribosomal phosphoprotein (P) antibodies Lupus, December 1, 2001; 10(12): 857 - 865. [Abstract] [PDF]

				J. George, A. Afek, B. Gilburd, M. Blank, Y. Levy, A. Aron-Maor, H. Levkovitz, A. Shaish, I. Goldberg, J. Kopolovic, et al. Induction of Early Atherosclerosis in LDL-Receptor–Deficient Mice Immunized With ß2-Glycoprotein I Circulation, September 15, 1998; 98(11): 1108 - 1115. [Abstract] [Full Text] [PDF]

				Y. Sheng, D. A. Kandiah, and S. A. Krilis Anti-{beta}2-Glycoprotein I Autoantibodies from Patients with the "Antiphospholipid" Syndrome Bind to {beta}2-Glycoprotein I with Low Affinity: Dimerization of {beta}2-Glycoprotein I Induces a Significant Increase in Anti-{beta}2-Glycoprotein I Antibody Affinity J. Immunol., August 15, 1998; 161(4): 2038 - 2043. [Abstract] [Full Text] [PDF]

				D A Kandiah and S A Krilis Anti-{beta}2-glycoprotein I and anti-prothrombin antibodies in patients with the 'antiphospholipid' syndrome: Immunological specificity and clotting profiles Lupus, June 1, 1998; 7(5): 323 - 332. [Abstract] [PDF]

				J. George, B. Gilburd, M. Hojnik, Y. Levy, P. Langevitz, E. Matsuura, T. Koike, and Y. Shoenfeld Target Recognition of {beta}2-Glycoprotein I ({beta}2GPI)-Dependent Anticardiolipin Antibodies: Evidence for Involvement of the Fourth Domain of {beta}2GPI in Antibody Binding J. Immunol., April 15, 1998; 160(8): 3917 - 3923. [Abstract] [Full Text] [PDF]

				S. S. Pierangeli, X. W. Liu, G. Anderson, J.H. Barker, and E.N. Harris Thrombogenic Properties of Murine Anti-Cardiolipin Antibodies Induced by ß2 Glycoprotein 1 and Human Immunoglobulin G Antiphospholipid Antibodies Circulation, October 1, 1996; 94(7): 1746 - 1751. [Abstract] [Full Text]